Ventilation mask

Information

  • Patent Grant
  • 11324909
  • Patent Number
    11,324,909
  • Date Filed
    Thursday, April 4, 2019
    5 years ago
  • Date Issued
    Tuesday, May 10, 2022
    2 years ago
Abstract
Disclosed is a nasal ventilation mask having separate ports to monitor end-tidal CO2 expulsion integrated into the mask in order to monitor end-tidal CO2 expelled nasally or orally. Also disclosed is a CPR mask for nose-to-mouth and/or mouth-to-mouth resuscitation, having a body shaped to cover the nose and/or mouth of a victim, the mask including a CO2 absorber for eliminating at least in part rescuer's exhaled CO2 delivered to the victim.
Description
BACKGROUND OF THE INVENTION

The present invention relates to improvements in anesthesia masks and ventilation masks.


During surgery a patient usually is placed under anesthesia. The most common delivery system consists of canisters containing anesthesia gases and oxygen, a system of regulating the gas flow and the patient's breathing, and a device ensuring the potency of the patient's airway for breathing, oxygenation and the delivery of the anesthetic gas mixture. A ventilation mask is used to provide oxygen to the patient either during emergency and/or elective airway management, which includes but is not limited to; before a patient is anesthetized for surgery, while the patient is anesthetized, if the patient is sedated during the surgery or procedure, while the patient is recovering from anesthesia, after the patient has recovered from anesthesia, or during any event where a patient requires supplemental oxygen. However, one of the drawbacks of mask ventilation is that it requires constant contact between the provider's hands and the patient's face to hold the mask in place and keep the patient in the sniffing position in order to ensure that oxygen and anesthetic gases do not leak out into the air and that the patient's airway remains patent. If the provider does not maintain the patient in the sniffing position, a dangerous complication known as upper airway obstruction may occur. The reason the provider needs to perform continuous mask holding and maneuvering is the human anatomy and physiology. When muscles of the jaw, tongue and upper airway relax due to sedatives and/or muscle relaxants given to the patient for sedation and/or anesthesia, the upper airway (mouth, pharynx, larynx) may become partially obstructed and possibly completely closed. Wherein, when the jaw of the patient drops and the tongue obstructs the airway resulting in snoring (partial obstruction) or apnea (complete inability for oxygen to pass via the upper airway into the lungs). Another problem exists when a provider fails to administer enough anesthesia or sedation or it begins to wear off and the patient begins to move. This can cause the patient's airway to obstruct as well since the patient's head and neck position are no longer in the sniffing position. Patient movement during surgery can also be dangerous because it can cause the surgeon to make a mistake, particularly in eye, ear, nose, neck, head, and throat surgery.


Furthermore, situations arise during surgery that require rapid intubation of a patient. Full face masks, i.e. masks covering both the nose and mouth of a patient are problematic in emergency situations since a mask must be removed to uncover the mouth of a patient for intubation. However, removing the mask also removes oxygen support. As will be described below, the present invention in one aspect addresses the aforesaid and other disadvantages of the prior art.


The present invention, in another aspect relates to cardiopulmonary resuscitation (CPR) masks.


Cardiopulmonary resuscitation, commonly known as CPR is an emergency procedure performed in an effort to manually preserve intact brain function until further measures may be taken to restore spontaneous blood circulation and breathing in a person (hereinafter the “subject” or “victim”) who is in cardiac arrest. CPR also is indicated in those who are unresponsive with no breathing such as in the case of a drowning victim or victim of electrical shock, or abnormal breathing, for example agonol respiration.


CPR involves chest compressions at least two inches deep and at a rate of at least 100 per minute in an effort to create artificial circulation by manually pumping blood through the heart and thus the body. The rescuer also may provide breaths by either exhaling directly into the subject's mouth, or through a CPR mask into the subject's mouth and/or nose (collectively “mouth-to-mouth resuscitation”), or using a device that pushes air into the subject's lungs through the subject's mouth and/or nose. The process of externally providing ventilation is termed “artificial respiration”. Current recommendations place emphasis on high-quality chest compressions over artificial respiration; however, when coupled with high-quality chest compressions, artificial respiration provides potentially the greatest benefit to the patient.


Conventional CPR masks are held in place by hand, by the CPR provider, or may be retained in position by straps that extend behind the head of the subject or victim. While CPR masks may assist in ventilation of a subject or victim who is not breathing, when a rescuer provides mouth-to-mouth and/or nose-to-mouth resuscitation, the air provided contains a significant amount of CO2 which is lethal. As will be discussed below, the present invention in another aspect addresses the aforesaid and other disadvantages of the prior art.


SUMMARY OF THE INVENTION

The present invention in one aspect provides an improved ventilation/anesthesia mask that overcomes the aforesaid and other problems of the prior art. More particularly, there is provided a nasal ventilation/anesthesia mask comprising one or more offset gas openings to allow the provider to have a clear view of the mouth and airway during direct laryngoscopy and intubation, which consists of a ventilation port to supply oxygen and other gases during anesthesia via Non-Invasive Positive Pressure Ventilation (NIPPV) and which is connected to an anesthesia circuit which can measure end-tidal CO2 from the nose, an oral opening port under the nose for scavenging anesthesia gases and end-tidal CO2 that are expelled orally from the patient; a gas scavenging/end-tidal CO2 port connected to a channel inside the mask that is isolated from the nasal cavity, and an oxygen port for supplying post op oxygen. Completing the mask are a plurality of tabs or eyelets, preferably three, or four, for strapping the mask to the patient's head or for tying the mask down to the operating table, e.g., in accordance with the teachings of our PCT application PCT/US14/44934 and on PCT application PCT/US15/34277.


In one embodiment of the invention there is provided a nasal ventilation mask having an O2 port for introducing oxygen into the mask, a ventilation port and a gas monitoring attachment integral to or attached to the ventilation port. In such embodiment, the gas monitoring port includes a luer lock.


In another embodiment of the invention, there is provided a nasal ventilation mask having an exterior opening under a nose region in the mask, over the patient's lip region, that allow gases expelled orally to be scavenged and ported to a scavenger device, said mask optionally further including a Scavenger line for diverting a portion of the expelled gas to be monitored for end-tidal CO2, and, wherein a connector preferably is provided at point where the end-tidal CO2 monitoring line intercepts the Scavenger line, effectively diverting the gas flow, resulting in a positive pressure relative to the end-tidal CO2 line whereby to permit gasses to be sampled from the scavenger line.


In such embodiment, the mask may further comprise an anesthesiologist controlled 2-way, 3 port valve permitting an anesthesiologist to switch between separately monitoring nasal and oral expulsions of end-tidal CO2 or monitoring them simultaneously when the valve is open to both, wherein, when the Oral end-tidal CO2 monitoring port is chosen, the end-tidal CO2 monitoring line preferably also serves to scavenge other ventilation gasses during anesthesia.


The present invention also provides a nasal ventilation mask having tabs or eyelets for attaching the mask anteriorly with the mask anchor, or posteriorly with a traditional anesthesia mask strap, said mask further optionally characterized by one or both of the following features:


(a) allowing only one combined anterior-posterior head strap to be attached, where the posterior head strap can attach to the mask alone, or can attach to the mask and then to a surface, which will prevent movement of the patient's head and/or neck; or


(b) securing the patient's head with a head strap to the support surface, where the patient's head will stay in a desired position and the support surface will stay in the desired position when the provider changes the head and/or neck angles.


In yet another embodiment of the invention there is provided a nasal mask characterized by one or more of the following features:


(a) wherein the mask is usable as an oxygen transport mask or as a Ventilation mask providing O2 and anesthesia gases and for monitoring end-tidal CO2 simultaneously;


(b) having ports for monitoring end-tidal CO2 via one or more ports, that can be used for CPAP pre-operatively, intra-operatively, and post-operatively;


(c) having ports for monitoring end-tidal CO2 via one or more ports, that can be connected to a resuscitator bag in such a way that the patient's mouth and airway are not obstructed by the resuscitator bag to allow for direct laryngoscopy and intubation;


(d) wherein the mask is attachable anteriorly with a mask anchor, or posteriorly with a traditional anesthesia mask strap; and


(e) having an O2 port for introducing oxygen into the mask, a ventilation port and a gas monitoring attachment integral to or attached to the ventilation port, wherein the gas monitoring port preferably includes a luer lock


The present invention also provides an anesthesia mask having a built in scavenger system for collecting anesthetic gases that leak out around the mouth and/or nose.


In yet another embodiment, the present invention provides a chin strap for application to the submental space, attached to a nasal mask, for applying pressure to force a wearer's tongue against the soft palate and induce an obstruction of the retro-glossal space, whereby to reduce or prevent leakage of gases out of the patient's mouth and allow the patient to breath out of the nose, wherein the chin strap also has the ability to release pressure, if needed, during exhalation to prevent an expiratory obstruction.


In another aspect the present invention provides an improved CPR mask for mouth-to-mouth and/or nose-to-mouth resuscitation and includes a CO2 absorber that eliminates re-breathing of rescuer or provider exhaled CO2 by the victim. More particularly, the present disclosure provides a CPR mask which includes a CO2 filter or absorber built into the mask or mask inlet for absorbing CO2 being exhaled by the rescuer or provider.


That is to say, there is provided a CPR mask for mouth-to-mouth and/or nose-to-mouth resuscitation, comprising a body shaped to cover the nose and/or mouth of a victim, said mask including a CO2 absorber for eliminating at least in part rescuer exhaled CO2 delivered to the victim.


In one embodiment, the CO2 absorber is coated on an inside surface of the mask.


In another embodiment, the mask includes a ventilation tube, wherein the CO2 absorber is located in the ventilation tube.


In still another embodiment the mask includes one-way valve and/or straps for holding the mask to the head of the victim.


In one embodiment the mask includes a compliant periphery to conform to the face of a victim. In such embodiment, the periphery may include a soft, compliant air bladder, or resiliently deformable foam cushion.


In yet another embodiment, the mask includes a biological filter incorporated into the inside of the mask, or incorporated into the ventilation tube.


In still yet another embodiment of the invention, there is provided a CPR mask as above described, further characterized by one or more of the following features:


(a) including a one-way valve;


(b) including straps for holding the mask to the head of the victim; and


(c) wherein the mask further includes a compliant periphery to conform to the face of a wearer, wherein the periphery preferably includes a soft, compliant air bladder or a resiliently deformable foam cushion.





BRIEF DESCRIPTION OF THE DRAWINGS

Further features and advantages of the present invention will be seen from the following detailed description, taken in conjunction with the accompany drawings, wherein



FIGS. 1a and 1b are front view and top views of a nasal ventilation mask in accordance with the first embodiment of the present invention;



FIG. 2 is an inside view of the FIG. 1a ventilation mask;



FIGS. 3a and 3b are plan views showing the ventilation mask in accordance with the present invention on a patient's head;



FIGS. 4a and 4b are views similar to FIGS. 3a and 3b showing a chin strap attached to the mask;



FIGS. 5a and 5b show an alternative configuration of the nasal mask with an end-tidal CO2 monitor in accordance with the present invention;



FIG. 6 is a side elevational view of an alternative configuration of nasal mask ventilation system in accordance with the present invention;



FIG. 7 is a plan view of an alternative embodiment of nasal ventilation mask with a CO2 monitor in accordance with the present invention;



FIG. 8 is a plan view of yet another alternative configuration of nasal mask with a CO2 monitor in accordance with the present invention;



FIG. 9 is a view, in partial cross-section of a CPR mask in accordance with the first embodiment of the present invention; and



FIG. 10 is a side elevational view of a second embodiment of a CPR mask in accordance with the present invention.





DETAILED DESCRIPTION OF THE DRAWINGS

A nasal ventilation mask 10 in accordance with a first embodiment of the present invention is illustrated in FIGS. 1a and 1b. Optimally it contains 4 gas openings, but can contain less or more than four as well. The first is the ventilation port 12 that supplies O2 and other gasses either during anesthesia or for NIPPV in critically ill patients and allows for any end-tidal CO2 that is expelled nasally to be retrieved from the patient. The second is an Oral opening 14 under the nose but isolated from the nasal cavity created by the mask over the patient's nose. The purpose of opening 14 is for scavenging anesthesia gases and end-tidal CO2 that are expelled orally from the patient. In addition to reducing or eliminating anesthetic gasses from entering the Operating Room and becoming a hazard, it allows for the end-tidal CO2 expelled from the patient's lungs and escaping orally to be monitored. The third opening is the Gas Scavenging/end-tidal CO2 port 16 that is connected to the opening by a channel 18 inside the mask (see FIG. 2) that is isolated from the nasal cavity. The Gases, including any expelled end-tidal CO2, leave the mask through port 16 and are guided by a tube 20 to a gas scavenging filter and end-tidal CO2 monitor 32 (see FIG. 3) that samples gas from the gas scavenging line. The fourth opening is an O2 port 22 that is capped off during anesthesia, but may be connected to an O2 source (not shown) either pre-operation, intra-operation, or post-operation. When O2 is supplied, the Ventilation tube is detached from the ventilation port 12 so that end-tidal CO2 and be expelled nasally. A gas hood 24 located under the nose around the oral opening 14 extends beyond the mask as shown. It is optionally included in order to extend the influence of the Oral Opening 14 in the mask in order to contain a greater percentage of the expelled gases from the patient.


The mask also includes three eyelets or tabs 60, 62, 64, or four eyelets or tabs 6668, 70, 72 (FIG. 7) for attaching a chin strap or head strap, as described below, or for attaching straps to the operating table in accordance with the teachings of our application PCT/US14/44934 or our PCT application PCT/US15/34277.


An interior view of the nasal ventilation mask 10 of the present invention is illustrated in FIG. 2. The ventilation port 12 and O2 port 22, are connected to the nasal cavity 26. Orally expelled gases travel from the Oral opening 14 on the outside of the mask through Gas Channel 18 and out the Gas Scavenger & end-tidal CO2 monitoring port 16 on to the Scavenger device and end-tidal CO2 monitor. The Gas channel 18 separates the Nasal cavity 26 created by the ventilation mask over the nose and the Oral regions of the patient.


When O2 or O2 and anesthesia gasses and are being supplied to the patient, they travel to the nasal cavity 26 through a ventilation circuit 28 attached to the ventilation port 12, and a cap shown in phantom at 30, seals the O2 port. Post operation, the cap 30 can be removed from the O2 port 22 and an O2 line attached to the port, supplying O2 to the patient. The ventilation circuit 28 is removed from the ventilation port 12 and the nasal cavity 26 is open to the atmosphere where end-tidal CO2 can be expelled nasally.


The gas circuit for both the Nasal Mask Ventilation/end-tidal CO2 monitor Oral Gas Scavenger/end-tidal CO2 monitoring lines are illustrated in FIGS. 3a and 3b. FIG. 3a shows nasal gas flow from the Nasal cavity 26 connected to the Ventilation Circuit 28 and to the end-tidal CO2 monitoring equipment 32. FIG. 3b shows the orally expelled gasses entering the Oral opening and flowing through the Gas Scavenger line to a recovery device 34 and the associated line that is connected to the scavenger line and flows to the end-tidal CO2 monitoring equipment. Note that the opening to the scavenger line should be positioned approximately 90° to the scavenger gas flow in order for the local pressure to be higher than it would be if the opening were perpendicular to the gas flow. If it were perpendicular, a negative pressure would prevent the end-tidal CO2 monitoring line from being able to sample the flow due to the negative pressure gradient.


Referring also to FIGS. 4a and 4b, a chin strap 36 also can be applied to the submental space, attached to the nasal mask 10, and apply a pressure to force the tongue against the soft palate and induce an obstruction of the retro-glossal space, which will help prevent any leak of gases out of the patient's mouth and allow the patient to breath out of the nose. The chin strap 36 also has the ability to release pressure, if needed, during exhalation to prevent an expiratory obstruction and allow end-tidal CO2 and other gases to be released out the mouth.


In an alternate configuration, the gas circuit for both the Nasal Mask Ventilation and end-tidal CO2 monitoring are illustrated in FIGS. 5a and 5b. The figure shows a 2-Way, 3 Port valve 40 that connects the Nasal circuit to the end-tidal CO2 monitoring equipment. The anesthesiologist decides which region, the nasal, oral region, or both simultaneously, should be monitored for end-tidal CO2.


A side view of the alternate configuration for the nasal mask ventilation and monitoring end-tidal CO2 expulsion from the oral airway is illustrated in FIG. 6. Note the 2-Way, 3 Port valve 40 has been turned in the direction of the mouth for sampling end-tidal CO2.


The nasal ventilation mask also allows only one combined anterior-posterior head strap to be attached, where the posterior head strap can attach to the mask alone, or can attach to the mask and then to a surface, which will prevent movement of the patient's head and/or neck. By securing the patient's head with the head strap to the support surface, the patient's head will stay in the desired position and the support surface will stay in the desired position when the provider changes the head and/or neck angles.



FIG. 7 illustrates yet another embodiment of the invention, in which a patient is being provided oxygen via an O2 line connected to the O2 port on the ventilation mask. The exhaled gasses are exhausted to the atmosphere via the ventilation port 12 as illustrated in FIG. 7. If the patient is unconscious due to anesthesia, there is a desire to assure that the CO2 is being exhaled. This can be accomplished by adding a “T-Shaped” gas monitoring attachment 50 that slides onto the mask ventilation port 12. The main body of the attachment 50 which is tubular in shape allows exhaled gasses to be exhausted to the atmosphere. To the side of the attachment is a tubular opening 52, nominally at a 90° angle off to the side. The end of this opening 52 can have a luer lock or any other kind of securing connection. Exhaled gas from the main flow can be sampled through this opening if a gas monitoring line 54 connected to a gas monitor is attached to the gas monitoring line interface.


An alternative approach for accomplishing the same gas sampling feature is illustrated in FIG. 8. In this embodiment, the gas monitoring line interface is an integral element of the mask ventilation port 12. In this configuration, O2 flows into the O2 port via a supply line and the exhaust gases are passed to the atmosphere via the ventilation port 12. The side of the ventilation port 12 is a tubular opening 56, nominally at 90° angle off to the side. The end of this opening can have a luer lock or any other kind of securing connection. Exhaled gas from the main flow can be sampled through this opening if a gas monitoring line connected to a gas monitor is attached to the gas monitoring line surface.


Referring to FIG. 9, there is shown a first embodiment of a CPR mask in accordance with another aspect of our invention, designated 110, to affect rescue breathing, mouth-to-mouth resuscitation or any other CPR procedure requiring emergency breathing assistance. Mask 110 is shaped to cover the nose and/or mouth of a victim, and includes a soft and compliant periphery 112 to conform to the face of a victim upon application of moderate force to obtain a tight-fitting mask seal. Typically the periphery 112 of the mask includes a soft, compliant air bladder 114 or resiliently deformable foam cushion or the like.


A ventilation tube 116 is attached to an integral inlet port 118 protruding from the mask through which air may be supplied by the rescuer by exhaling into the tube. Ventilation tube 116 or inlet port 118 typically includes a one-way valve 120 that permits air to enter the mask through tube 116. Ventilation tube 116 and its associated valve 120 may be formed integrally with the port 118, or may be a replaceable, disposable element or package. (FIG. 10).


The inside surface 122 of mask 110 is coated in part by a CO2 absorbing material such as activated carbon or a zeolite. Also, certain minerals such as serpentinite advantageously may be employed. Typically, these materials are sorted to optimal size and encased in a filter material 124 bound to the inside surface 122 of the mask 110. Alternatively, the inside surface 122 of the mask 110 may be coated with a CO2 absorbing polymer such as polyethylenimine containing fumed silica or the like as reported in Scientific American, Jan. 6, 2012, page 33.


Alternatively, as shown in FIG. 10, a CO2 filter 126 containing CO2 absorbing material may be incorporated into ventilation tube 116.


In use, the rescuer places the CPR mask 110 over the nose and/or mouth of a victim to initiate emergency ventilation of the victim. The rescuer applies moderate force to obtain a substantially air-tight seal against the victim's face, and ventilation is then supplied by the rescuer by exhaling into the ventilation tube 116. While the exhaust from the rescuer contains CO2, most of the CO2 will be removed by the CO2 filter material.


Mask 110 may be formed in different sizes, for example, adult size, youth size and child size, to accommodate different size faces. A feature and advantage of the CPR mask of the present invention is that significantly reduces the amount of CO2 administered to the victim. Also, the mask helps to protect both victim and rescuer in an emergency situation by preventing transfer of disease.


Various changes may be made in the above invention without departing from the spirit and scope thereof. For example, a biological filter (shown in phantom at 130 in FIG. 10) also may be incorporated into the mask or the ventilation tube 116. Additionally, the mask may include straps 132 for strapping the mask to the victim's head, thus freeing the rescuer from having to press the mask against the victim's face. Still other changes are possible.

Claims
  • 1. A nasal ventilation mask having a body defining a nasal cavity having an interior configured to cover a patient's nose while leaving a patient's mouth uncovered, the mask having an O2 port, a ventilation port, and an end-tidal CO2 port, the O2 port fluidly coupled to the nasal cavity for introducing oxygen into the nasal cavity, the ventilation port fluidly coupled to the nasal cavity for directing a gas toward or away from the nasal cavity, and the end-tidal CO2 port fluidly coupled to an exterior opening under a nose region of the mask, adapted to overlie a patient's lip region and isolated from the nasal cavity, wherein the end-tidal CO2 port is configured to couple with a monitoring line, and the ventilation port is configured to couple with a ventilation line that is different than the monitoring line, and the exterior opening is adapted to scavenge gases expelled orally by a wearer.
  • 2. The mask of claim 1, wherein the mask is adapted for use as an oxygen transport mask, or as a ventilation mask providing O2 and anesthesia gases.
  • 3. The mask of claim 1, wherein the mask is adapted for CPAP pre-operatively, intra-operatively, and/or post-operatively.
  • 4. The mask of claim 1, wherein the mask is adapted for connection to a resuscitator bag such that a patient's mouth and airway are not obstructed by the resuscitator bag, to allow for direct laryngoscopy and intubation.
  • 5. The mask of claim 1, wherein the mask comprises a gas channel inside the nasal cavity, wherein the gas channel fluidly couples the end-tidal CO2 port to the exterior opening and is configured to isolate orally expelled gases from a rest of the cavity.
  • 6. The mask of claim 1, wherein the mask comprises a gas monitoring attachment.
  • 7. The mask of claim 6, wherein the gas monitoring attachment is integral to or attached to the ventilation port.
  • 8. The mask of claim 1, further comprising an anesthesiologist controlled 2-way, 3 port valve permitting an anesthesiologist to switch between separately monitoring nasal and oral end-tidal CO2, or simultaneously monitoring nasal and oral end-tidal CO2, wherein when oral end-tidal CO2 monitoring is chosen, ventilation gases expelled orally by the patient are also monitored.
  • 9. The mask of claim 1, wherein the mask comprises a scavenger line configured to for diverting at least a portion of the scavenged gas to an end-tidal CO2 monitor.
  • 10. The mask of claim 9, wherein a connector is provided where the monitoring line intercepts the scavenger line, diverting gas flow, resulting in a positive pressure relative to the monitoring line, to permit gases to be sampled from the scavenger line.
  • 11. A nasal ventilation mask comprising a body defining a nasal cavity having an interior configured to cover a patient's nose while leaving a patient's mouth uncovered, the mask having a first port fluidly coupled to the nasal cavity and configured for introducing oxygen into the nasal cavity, a second port fluidly coupled to the nasal cavity and configured for directing a gas toward or away from the nasal cavity, and a third port fluidly coupled to an exterior opening under a nose region of the mask, wherein the exterior opening is isolated from the nasal cavity and is adapted to overlie a patient's lip region, and the third port is configured to couple with a monitoring line, the second port is configured to couple with a ventilation line that is different than the monitoring line, and the exterior opening is adapted to scavenge gases expelled orally by a wearer.
  • 12. The mask of claim 11, wherein the mask comprises a gas channel inside the nasal cavity, wherein the gas channel fluidly couples the third port to the exterior opening.
  • 13. The mask of claim 11, wherein the mask comprises a gas monitoring attachment.
  • 14. The mask of claim 13, wherein the gas monitoring attachment is integral to or attached to the second port.
  • 15. The mask of claim 11, further comprising an anesthesiologist controlled 2-way, 3 port valve permitting an anesthesiologist to switch between separately or simultaneously monitoring any of the first, second, and third ports.
  • 16. An anesthesia mask having a body defining a nasal cavity having an interior configured to cover a patient's nose while leaving a patient's mouth uncovered, the anesthesia mask having a first port, a second port, and a third port, and a scavenger system, the first port fluidly coupled to the nasal cavity and configured for introducing oxygen into the nasal cavity, the second port fluidly coupled to the nasal cavity and configured for directing a gas toward or away from the nasal cavity, and the third port coupled to an exterior opening under a nose region of the mask and adapted to overlie a patient's lip region, and the scavenger system configured for collecting anesthetic gases that may leak out around a mouth and nose of a patient, the scavenger system comprising the third port and a gas hood, the gas hood located under the nose region of the anesthesia mask and extending from an outer surface of the anesthesia mask around the exterior opening to enhance the collection of anesthetic gases around the patient's mouth, wherein the third port is configured to couple with a monitoring line, and the second port is configured to couple with a ventilation line that is different than the monitoring line.
  • 17. The mask of claim 16, wherein the mask comprises a gas channel inside the nasal cavity, wherein the gas channel fluidly couples the third port to the exterior opening.
  • 18. The mask of claim 16, wherein the mask comprises a gas monitoring attachment.
  • 19. The mask of claim 18, wherein the gas monitoring attachment is integral to or attached to the second port.
  • 20. The mask of claim 16, further comprising an anesthesiologist controlled 2-way, 3 port valve permitting an anesthesiologist to switch between separately or simultaneously monitoring any of the first, second, and third ports.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/272,160, filed Sep. 21, 2016, which is a continuation of U.S. patent application Ser. No. 15/127,758, filed Sep. 20, 2016, which in turn claims priority from PCT Patent Application Serial No. PCT/US2015/044341, filed Aug. 7, 2015, which claims priority from U.S. Provisional Application Ser. No. 62/039,759, filed Aug. 20, 2014, and from U.S. Provisional Application Ser. No. 62/078,677, filed Nov. 12, 2014, and from U.S. Provisional Application Ser. No. 62/161,041, filed May 13, 2015, the disclosure of each of which is incorporated herein by reference in its entirety.

US Referenced Citations (374)
Number Name Date Kind
1050621 Ford Jan 1913 A
1131802 Stenshoel Mar 1915 A
1441817 McCullough Jan 1923 A
1729525 Stenshoel Sep 1929 A
1776167 Stenshoel Sep 1930 A
2452816 Wagner Nov 1948 A
2843121 Hudson Jul 1958 A
2939458 Lundquist Jun 1960 A
3013556 Galleher Dec 1961 A
3522612 Palmer Aug 1970 A
3556097 Wallace Jan 1971 A
3799164 Rollins Mar 1974 A
3815596 Keener et al. Jun 1974 A
3856051 Bain Dec 1974 A
3889668 Ochs et al. Jun 1975 A
3897777 Morrison Aug 1975 A
D242490 Belkin Nov 1976 S
4005499 Klein Feb 1977 A
4007737 Paluch Feb 1977 A
4015598 Brown Apr 1977 A
4188946 Watson et al. Feb 1980 A
D256161 Oliver Jul 1980 S
4231363 Grimes Nov 1980 A
4232667 Chalon et al. Nov 1980 A
4248218 Fischer Feb 1981 A
4259757 Watson Apr 1981 A
4265235 Fukunaga May 1981 A
4265239 Fischer, Jr. May 1981 A
4275720 Wichman Jun 1981 A
4328797 Rollins May 1982 A
4457026 Morris Jul 1984 A
4463755 Suzuki Aug 1984 A
4471769 Lockhart Sep 1984 A
4574796 Lundstrom Mar 1986 A
4596246 Lyall Jun 1986 A
4657010 Wright Apr 1987 A
4700691 Tari et al. Oct 1987 A
4770169 Schmoegner et al. Sep 1988 A
4905712 Bowlin et al. Mar 1990 A
5046200 Feder Sep 1991 A
5046491 Derrick Sep 1991 A
5121746 Sikora Jun 1992 A
D333404 Thompson Feb 1993 S
5220699 Farris Jun 1993 A
5243971 Sullivan et al. Sep 1993 A
5255303 DiMaio et al. Oct 1993 A
5271390 Gray et al. Dec 1993 A
5284160 Dryden Feb 1994 A
D347494 Mustelier May 1994 S
D354128 Rinehart Jan 1995 S
5404873 Leagre et al. Apr 1995 A
5462050 Dahlstrand Oct 1995 A
5474060 Evans Dec 1995 A
5485837 Solesbee et al. Jan 1996 A
5524639 Lanier et al. Jun 1996 A
D373921 Palomo et al. Sep 1996 S
5557049 Ratner Sep 1996 A
RE35339 Rapoport Oct 1996 E
5560354 Berthon-Jones et al. Oct 1996 A
5586551 Hilliard Dec 1996 A
5647357 Barnett et al. Jul 1997 A
5649331 Wilkinson et al. Jul 1997 A
5660174 Jacobelli Aug 1997 A
5661859 Schaefer Sep 1997 A
5685298 Idris Nov 1997 A
5738094 Hoftman Apr 1998 A
5746201 Kidd May 1998 A
5749358 Good et al. May 1998 A
5778872 Fukunaga et al. Jul 1998 A
D402755 Kwok Dec 1998 S
5884624 Barnett et al. Mar 1999 A
5933886 Washington Aug 1999 A
5960494 Gilliland Oct 1999 A
5966763 Thomas et al. Oct 1999 A
5975079 Hellings et al. Nov 1999 A
5983896 Fukunaga et al. Nov 1999 A
6003511 Fukunaga et al. Dec 1999 A
6019101 Cotner et al. Feb 2000 A
6035852 Hoftman Mar 2000 A
6058933 Good et al. May 2000 A
D428987 Kwok Aug 2000 S
6112746 Kwok et al. Sep 2000 A
6123071 Berthon-Jones et al. Sep 2000 A
6129082 Leagre Oct 2000 A
6152137 Schwartz et al. Nov 2000 A
D435650 Kwok Dec 2000 S
6192886 Rudolph Feb 2001 B1
6216691 Kenyon et al. Apr 2001 B1
6263874 LeDez Jul 2001 B1
6342040 Starr et al. Jan 2002 B1
6357441 Kwok et al. Mar 2002 B1
6397847 Scarberry et al. Jun 2002 B1
6401713 Hill et al. Jun 2002 B1
6412487 Gunaratnam et al. Jul 2002 B1
6412488 Barnett et al. Jul 2002 B1
6439230 Gunaratnam et al. Aug 2002 B1
6439231 Fukunaga et al. Aug 2002 B1
6446288 Pi Sep 2002 B1
6459923 Plewes et al. Oct 2002 B1
6463931 Kwok et al. Oct 2002 B1
6467483 Kopacko et al. Oct 2002 B1
D467345 Gingles et al. Dec 2002 S
6513526 Kwok et al. Feb 2003 B2
6520182 Gunaratnam et al. Feb 2003 B1
6581602 Kwok Jun 2003 B2
6584977 Serowski Jul 2003 B1
6612306 Mault Sep 2003 B1
6615835 Cise Sep 2003 B1
6626178 Morgan et al. Sep 2003 B2
6645835 Cise Sep 2003 B1
6631713 Christopher Oct 2003 B1
6631718 Lovell Oct 2003 B1
6634358 Kwok et al. Oct 2003 B2
6651663 Barnett et al. Nov 2003 B2
6694973 Dunhao et al. Feb 2004 B1
6701927 Kwok et al. Mar 2004 B2
6729333 Barnett et al. May 2004 B2
6736139 Wix May 2004 B1
D493523 Barnett et al. Jul 2004 S
6779524 Strawder et al. Aug 2004 B2
6792943 Kumar et al. Sep 2004 B2
6796308 Gunaratnam et al. Sep 2004 B2
6805117 Ho et al. Oct 2004 B1
6832610 Gradon et al. Dec 2004 B2
6863071 Annett et al. Mar 2005 B2
6871649 Kwok et al. Mar 2005 B2
6892729 Smith et al. May 2005 B2
6895965 Scarberry et al. May 2005 B2
6931664 Chen Aug 2005 B1
6935337 Virr et al. Aug 2005 B2
6981503 Shapiro Jan 2006 B1
7004168 Mace et al. Feb 2006 B2
7007696 Palkon et al. Mar 2006 B2
7013896 Schmidt Mar 2006 B2
7017576 Olsen et al. Mar 2006 B2
7021311 Gunaratnam et al. Apr 2006 B2
7028981 Horton Apr 2006 B2
7036508 Kwok May 2006 B2
7047971 Ho et al. May 2006 B2
7066179 Eaton et al. Jun 2006 B2
7069932 Eaton et al. Jul 2006 B2
7069933 Kwok et al. Jul 2006 B2
7114498 Nashed Oct 2006 B1
7159587 Drew et al. Jan 2007 B2
7178524 Noble Feb 2007 B2
7178527 Kwok et al. Feb 2007 B2
7210481 Lovell et al. May 2007 B1
7219669 Lovell et al. May 2007 B1
7237551 Ho et al. Jul 2007 B2
7243651 Kwok et al. Jul 2007 B2
7287528 Ho et al. Oct 2007 B2
7341060 Ging et al. Mar 2008 B2
7383839 Porat et al. Jun 2008 B2
7445602 Yamamori Nov 2008 B2
7448386 Ho et al. Nov 2008 B2
7467431 Weedling et al. Dec 2008 B2
7487772 Ging et al. Feb 2009 B2
7487777 Gunaratnam et al. Feb 2009 B2
7500280 Dixon et al. Mar 2009 B2
7500482 Biederman Mar 2009 B2
7614398 Virr et al. Nov 2009 B2
7631644 Ho et al. Dec 2009 B2
7665464 Kopacko et al. Feb 2010 B2
7669599 Gunaratnam et al. Mar 2010 B2
7700129 Ito et al. Apr 2010 B2
7743767 Ging et al. Jun 2010 B2
7753051 Burrow et al. Jul 2010 B2
7779832 Ho Aug 2010 B1
7841988 Yamamori Nov 2010 B2
7870859 Barnett et al. Jan 2011 B2
7874292 Smith et al. Jan 2011 B2
7913337 Masson Mar 2011 B1
7926487 Drew et al. Apr 2011 B2
7927285 Yamamori Apr 2011 B2
7931024 Ho et al. Apr 2011 B2
7938117 Chiesa et al. May 2011 B2
7950392 Kwok et al. May 2011 B2
7975694 Ho Jul 2011 B2
7997267 Ging et al. Aug 2011 B2
8001968 Doty et al. Aug 2011 B2
8001970 King et al. Aug 2011 B2
8028699 Ho et al. Oct 2011 B2
8042539 Chandran et al. Oct 2011 B2
8042541 Amarasinghe et al. Oct 2011 B2
8056561 Kwok et al. Nov 2011 B2
8132270 Lang et al. Mar 2012 B2
8161971 Jaffe Apr 2012 B2
8191553 Haworth et al. Jun 2012 B2
8210181 Gunaratnam et al. Jul 2012 B2
8261745 Chandran et al. Sep 2012 B2
8261746 Lynch et al. Sep 2012 B2
8267091 Smith et al. Sep 2012 B2
8302224 Lehman Nov 2012 B2
8312883 Gunaratnam et al. Nov 2012 B2
8336142 See et al. Dec 2012 B1
8336549 Nashed Dec 2012 B2
8347889 Farnum Jan 2013 B2
8365734 Lehman Feb 2013 B1
8397724 Sher et al. Mar 2013 B2
D681383 Derman et al. May 2013 S
8443807 McAuley et al. May 2013 B2
8485190 Barnett et al. Jul 2013 B2
8485192 Davidson et al. Jul 2013 B2
8490623 Berthon-Jones et al. Jul 2013 B2
RE44453 Virr et al. Aug 2013 E
8479726 McAuley Sep 2013 B2
8522783 Kwok et al. Sep 2013 B2
8528558 Drew et al. Sep 2013 B2
8539953 Moenning, Jr. Sep 2013 B2
8550081 Davidson et al. Oct 2013 B2
8550082 Davidson et al. Oct 2013 B2
8550083 Davidson et al. Oct 2013 B2
8555885 Davidson et al. Oct 2013 B2
8567402 Gunaratnam et al. Oct 2013 B2
8567404 Davidson et al. Oct 2013 B2
D693603 Esquivel et al. Nov 2013 S
8573211 Ho et al. Nov 2013 B2
8573212 Lynch et al. Nov 2013 B2
8573213 Davidson et al. Nov 2013 B2
8573214 Davidson et al. Nov 2013 B2
8573215 Davidson et al. Nov 2013 B2
8573217 Todd et al. Nov 2013 B2
8578935 Davidson et al. Nov 2013 B2
8578939 Kimani Mwangi et al. Nov 2013 B1
8613280 Davidson et al. Dec 2013 B2
8613281 Davidson et al. Dec 2013 B2
8616211 Davidson et al. Dec 2013 B2
8631792 Ho et al. Jan 2014 B2
8636006 Kwok et al. Jan 2014 B2
8667965 Gunaratnam et al. Mar 2014 B2
8684004 Eifler Apr 2014 B2
8689366 Ho Apr 2014 B2
8707950 Rubin Apr 2014 B1
8714157 McAuley et al. May 2014 B2
8752551 Chandran et al. Jun 2014 B2
8807134 Ho et al. Aug 2014 B2
8807135 Worboys et al. Aug 2014 B2
8813748 Kwok et al. Aug 2014 B2
8881728 Sher et al. Nov 2014 B2
8915861 Yamamori et al. Dec 2014 B2
8939151 McAuley et al. Jan 2015 B2
8944061 D'Souza et al. Feb 2015 B2
D726303 Rollins Apr 2015 S
9010330 Barlow et al. Apr 2015 B2
9010331 Lang et al. Apr 2015 B2
9022029 Varga et al. May 2015 B2
9027556 Ng et al. May 2015 B2
9138169 Beard Sep 2015 B2
9186474 Rollins Nov 2015 B1
9295799 McAuley et al. Mar 2016 B2
9295800 Davidson et al. Mar 2016 B2
D753287 Darab Apr 2016 S
D753816 Beard Apr 2016 S
9375545 Darkin et al. Jun 2016 B2
20020074001 Kwok et al. Jun 2002 A1
20020174868 Kwok et al. Nov 2002 A1
20030024533 Sniadach Feb 2003 A1
20030145859 Bohn et al. Aug 2003 A1
20030183232 Fukunaga et al. Oct 2003 A1
20040069306 Moenning Apr 2004 A1
20040221850 Ging et al. Nov 2004 A1
20040261800 Frank Dec 2004 A1
20050028811 Nelson et al. Feb 2005 A1
20050145247 Nashed Jul 2005 A1
20050160532 Froelich Jul 2005 A1
20050193493 Gabbay Sep 2005 A1
20060032500 Ghiron et al. Feb 2006 A1
20060042631 Martin et al. Mar 2006 A1
20060118117 Berthon-Jones et al. Jun 2006 A1
20060124131 Chandran et al. Jun 2006 A1
20060168730 Menkedick et al. Aug 2006 A1
20060174889 Noble Aug 2006 A1
20060231091 Camarillo Oct 2006 A1
20060249160 Scarberry Nov 2006 A1
20070062536 McAuley et al. Mar 2007 A1
20070113847 Acker et al. May 2007 A1
20070113856 Acker et al. May 2007 A1
20070267017 McAuley et al. Nov 2007 A1
20070271699 Sacchetti Nov 2007 A1
20070295335 Nashed Dec 2007 A1
20080053446 Sleeper et al. Mar 2008 A1
20080092895 Bimkrant Apr 2008 A1
20080092898 Schneider et al. Apr 2008 A1
20080196715 Yamamori Aug 2008 A1
20080221470 Sather et al. Sep 2008 A1
20080230067 Kwok et al. Sep 2008 A1
20090020127 Boone et al. Jan 2009 A1
20090084385 Lang Apr 2009 A1
20090114229 Frater et al. May 2009 A1
20090114230 Hernandez et al. May 2009 A1
20090133696 Remmers et al. May 2009 A1
20090178680 Chang Jul 2009 A1
20090250054 Loncar Oct 2009 A1
20090250061 Marasigan Oct 2009 A1
20090260628 Flynn Oct 2009 A1
20090301472 Kim Dec 2009 A1
20090320850 Wallnewitz et al. Dec 2009 A1
20100122701 Gunaratnam et al. May 2010 A1
20100122705 Moenning, Jr. May 2010 A1
20100147313 Albrecht Jun 2010 A1
20100170513 Bowditch Jul 2010 A1
20100170516 Grane Jul 2010 A1
20100218316 Nissen et al. Sep 2010 A1
20100224199 Smith et al. Sep 2010 A1
20100275919 Sung Nov 2010 A1
20100313891 Veliss et al. Dec 2010 A1
20110054366 Smith et al. Mar 2011 A1
20110072582 Patterson et al. Mar 2011 A1
20110083670 Walacavage Apr 2011 A1
20110092930 Poorman Apr 2011 A1
20110108035 Samaniego May 2011 A1
20110114099 Goldstein May 2011 A1
20110155136 Lee Jun 2011 A1
20110173750 Lehmann Jul 2011 A1
20110186050 Daly Aug 2011 A1
20110214674 Ging et al. Sep 2011 A1
20110220113 Newman Sep 2011 A1
20110253150 King Oct 2011 A1
20110265796 Amarasinghe et al. Nov 2011 A1
20110290253 McAuley et al. Dec 2011 A1
20120080035 Guney et al. Apr 2012 A1
20120111330 Gartner May 2012 A1
20120144588 Heimbrock et al. Jun 2012 A1
20120180220 Popitz Jul 2012 A1
20120222680 Eves et al. Sep 2012 A1
20120227736 Bowsher Sep 2012 A1
20120234326 Mazzone et al. Sep 2012 A1
20120247475 Hernandez et al. Oct 2012 A1
20120285455 Varga et al. Nov 2012 A1
20120285466 Pierro et al. Nov 2012 A1
20130014760 Matula, Jr. et al. Jan 2013 A1
20130023729 Vazales Jan 2013 A1
20130060157 Beard Mar 2013 A1
20130109992 Guyette May 2013 A1
20130146060 Ho et al. Jun 2013 A1
20130186413 Haines et al. Jul 2013 A1
20130190643 Brambilla Jul 2013 A1
20130192601 Reischl et al. Aug 2013 A1
20130192602 Leibitzki et al. Aug 2013 A1
20130199537 Formica et al. Aug 2013 A1
20130319417 Weinman Dec 2013 A1
20140076311 Darab Mar 2014 A1
20140083425 Moenning, Jr. Mar 2014 A1
20140144448 Eifler May 2014 A1
20140158135 Shyong Jun 2014 A1
20140158136 Romagnoli et al. Jun 2014 A1
20140215687 Andrews Aug 2014 A1
20140243600 Eisenberger Aug 2014 A1
20140243698 Koch Aug 2014 A1
20140245537 Allen Sep 2014 A1
20140251333 Burk Sep 2014 A1
20140276178 Simon Sep 2014 A1
20140326246 Chodkowski et al. Nov 2014 A1
20140352072 Holladay Dec 2014 A1
20140360504 Kwok Dec 2014 A1
20150047647 Winer Feb 2015 A1
20150059759 Frater et al. Mar 2015 A1
20150144140 Eury May 2015 A1
20150151070 Capra Jun 2015 A1
20150217075 Nair Aug 2015 A1
20150238716 Budhiraja et al. Aug 2015 A1
20150250970 Bowsher Sep 2015 A1
20150250971 Bachelder et al. Sep 2015 A1
20150273170 Bachelder et al. Oct 2015 A1
20150273171 Sullivan et al. Oct 2015 A1
20150335852 Miller Nov 2015 A1
20160015923 Chodkowski et al. Jan 2016 A1
20160022944 Chodkowski et al. Jan 2016 A1
20160038709 Beard Feb 2016 A1
20160067441 Bearne et al. Mar 2016 A1
20160151222 Pedro Jun 2016 A1
20160184540 Kokko Jun 2016 A1
20160213871 Darab Jul 2016 A1
20160279368 Isenberg Sep 2016 A1
Foreign Referenced Citations (29)
Number Date Country
2363900 May 2003 CA
202478364 Oct 2012 CN
202505937 Oct 2012 CN
103153378 Jun 2013 CN
19947722 Apr 2001 DE
2433666 Mar 2012 EP
187863 Nov 1922 GB
2209950 Jun 1989 GB
2456136 Jul 2009 GB
H02502161 Jul 1990 JP
H05507004 Oct 1993 JP
2005318975 Nov 2005 JP
2007181661 Jul 2007 JP
2008511399 Apr 2008 JP
3192368 Aug 2014 JP
2019103858 Jun 2019 JP
WO-2010059592 May 2010 WO
WO-2012106373 Aug 2012 WO
WO-2013036839 Mar 2013 WO
WO-2013064950 May 2013 WO
WO-2013142909 Oct 2013 WO
WO-2014038959 Mar 2014 WO
WO-2014210606 Dec 2014 WO
WO-2015063283 May 2015 WO
WO-2015131262 Sep 2015 WO
WO-2015147947 Oct 2015 WO
WO-2015187995 Dec 2015 WO
WO-2016007749 Jan 2016 WO
WO-2016097948 Jun 2016 WO
Non-Patent Literature Citations (102)
Entry
Australian Office Action for Application No. 2020204637, dated Mar. 26, 2021, 5 pages.
Extended European Search Report for Application No. 211607098, dated Apr. 22, 2021, 7 pages.
Japanese Office Action for Application No. 2019041441, dated Feb. 4, 2020, 20 pages.
Japanese Office Action for Application No. 2019041441, dated Aug. 25, 2020, 6 pages.
Australian Office Action for Application No. 2015305893, dated Mar. 21, 2020, 5 pages.
Australian Certificate of Registration issued in application No. 201512961, dated Aug. 7, 2015, 5 pages.
Australian Certificate of Registration issued in application No. 201512962, dated Aug. 11, 2015, 5 pages.
Ball et al., “Performance comparison of two anaesthetic facemasks”, Anaesth Intensive Care, Apr. 2007, vol. 35, Issue 2, 226-9 (abstract only), 2 pages.
Canadian Office Action issued in Application No. 162891, dated Apr. 5, 2016, 1 page.
Canadian Office Action issued in Application No. 162891, dated Nov. 10, 2015, 7 pages.
Chinese Notification of Grant for Application No. 201530191921.6, dated Feb. 15, 2016, 12 pages.
Chinese Office Action (w/translation) for Application No. 201480042735.9, dated Apr. 5, 2017, 18 pages.
Chinese Office Action for Application No. 201480042735.9, dated Nov. 6, 2017, 21 pages.
Chinese Office Action for Application No. 201580029981.5, dated Sep. 5, 2018, 14 pages.
Chinese Office Action for Application No. 201730161613.8, dated Aug. 7, 2017, 2 pages.
Chinese Office Action for Application No. 201730161613.8, dated Sep. 19, 2017, 11 pages.
CPAP product description, http://www.cpap.com/productpage/pr-amara-full-face-cpap-mask-gel-silicone.html, downloaded Jul. 28, 2016, 11 pages.
CPAPXCHANGE product image, http://www.cpapexchange.com/cpap-masks-bipap-masks/bluegel-full-cushion-comfortgel-cpap-bipap-masks.jpg, downloade Jul. 28, 2016, 1 page.
DirectHome Medical product description, http://www.directhomemedical.com/profilelite-gel-cpap-mask-philipsrespironics.html#.VwXLIPkrLIU, downloaded Jul. 28, 2016, 6 pages.
English Translation of Japanese Office Action for Application No. 2016-005262, dated Jun. 30, 2016, 1 page.
English Translation of Japanese Office Action for Application No. 2016-005263, dated Jun. 30, 2016, 1 page.
European Office Action for Application No. 003933217-0001, dated May 16, 2017, 2 pages.
European Partial Supplementary European Search Report for Application No. 14818563.0, dated Jan. 30, 2017, 6 pages.
Extended European Search Report for Application No. 14818563.0, dated May 3, 2017, 12 pages.
Extended European Search Report for Application No. 15803670.7, dated Oct. 24, 2018, 12 pages.
Extended European Search Report for Application No. 15833101.7, dated Jul. 3, 2018, 13 pages.
Indian Office Action for Indian Design Patent Application No. 272704, dated Aug. 28, 2015, 13 pages.
InnoMed Technologies Sylent Mask product description, http://innomedinc.com/sylent-ne-disposable-nasal-mask/, downloaded Jul. 28, 2016, 2 pages.
InnoMed Technologies, Hybrid Mask product description, http://innomedinc.com/hybrid/, downloaded Jul. 28, 2016, 4 pages.
International Preliminary Report on Patentability for Application No. PCT/US2014/044934, dated Jan. 7, 2016, 12 pages.
International Preliminary Report on Patentability for Application No. PCT/US2015/021323, dated Oct. 6, 2016, 8 pages.
International Preliminary Report on Patentability for Application No. PCT/US2015/044341, dated Mar. 2, 2017, 10 pages.
International Preliminary Report on Patentability for Application No. PCT/US2016/037070, dated Dec. 12, 2017, 7 pages.
International Search Report and Written Opinion for Application No. PCT/US2017/048046, dated Nov. 6, 2017, 11 pages.
Invitation to Pay Additional Fees for Application No. PCT/US14/44934, dated Oct. 24, 2014, 3 pages.
Invitation to Pay Additional Fees for Application No. PCT/US15/44341, dated Oct. 21, 2015, 2 pages.
Israeli Notice of Allowance for Application No. 57056 (w/translation of relevant portions), dated Nov. 1, 2015, 3 pages.
Israeli Notice of Allowance for Applicatoin No. 57056 (no translation), dated May 29, 2016, 1 page.
Israeli Office Action for Application No. 57850 (w/translation of relevant portions), dated Feb. 14, 2016, 3 pages.
Israeli Office Action for Application No. 58250 (w/translation of relevant portions), dated Jun. 29, 2016, 2 pages.
Israeli Office Action issued in application No. 58250 (w/translation of relevant portions), dated Jul. 18, 2016, 3 pages.
Japanese Decision for Registration (w/translation) for Application No. 2016-006559, dated May 12, 2017, 2 pages.
Japanese Decision for Registration (w/translation) for Application No. 2016-006560, dated May 12, 2017, 2 pages.
Japanese Decision for Registration for Application No. 2016-005263, dated Dec. 22, 2017, 4 pages.
Japanese Decision for Registration for Application No. 2017-009813, dated Oct. 6, 2017, 2 pages.
Japanese Office Action (w/translation) for Application No. 2016-005262, dated Apr. 28, 2017, 7 pages.
Japanese Office Action (w/translation) for Application No. 2016-005263, dated Apr. 28, 2017, 7 pages.
Japanese Office Action (w/translation) for Application No. 2016-006559, dated Sep. 2, 2016, 3 pages.
Japanese Office Action (w/translation) for Application No. 2016-006560, dated Sep. 2, 2016, 3 pages.
Japanese Office Action for Application No. 2015-013148, dated Dec. 18, 2015, 3 pages.
Japanese Office Action for Application No. 2016-005262, dated Dec. 22, 2017, 4 pages.
Japanese Office Action for Application No. 2017-009813, dated Jul. 28, 2017, 3 pages.
Japanese Office Action for Application No. 2017-509724, dated Jul. 24, 2018, 12 pages.
Korean Design of Registration for Application No. 30-2015-0029561, M002 (w/translation), dated Jul. 27, 2016, 3 pages.
Korean Notice of Design of Registration for Application No. 30-2015-0029561, M001 (w/translation), dated Jun. 29, 2016, 3 pages.
Korean Office Action for Application No. 30-2015-0029561, M0001, dated Jun. 9, 2016, 16 pages.
Korean Office Action for Application No. 30-2015-0029561, M001 (w/translation), dated Dec. 24, 2015, 12 pages.
Korean Office Action for Application No. 30-2015-0029561, M001, dated May 23, 2016, 2 pages.
Korean Office Action for Application No. 30-2015-0029561, M002 (w/translation), dated Dec. 24, 2015, 7 pages.
Korean Office Action for Application No. 30-2015-0029561, M002 (w/translation), dated May 23, 2016, 6 pages.
Liang, Yafen et al., “Nasal Ventilation is More Effective than Combined Oral-Nasal Ventilation during Induction of General Anesthesia in Adult Subjects”, Anesthesiology 2008, vol. 108, No. 6, Jun. 2008, pp. 998-1003.
Notice of Allowance (corrected) for U.S. Appl. No. 15/288,973, dated Feb. 10, 2017, 16 pages.
Notice of Allowance (corrected) for U.S. Appl. No. 15/288,973, dated Mar. 10, 2017, 9 pages.
Notice of Allowance (corrected) for U.S. Appl. No. 15/288,973, dated Mar. 24, 2017, 9 pages.
Notice of Allowance for U.S. Appl. No. 15/288,973, dated Feb. 1, 2017, 25 pages.
Notice of Decision of Registration for Design for Korean Design Application No. 30-20016-0014111, dated Dec. 13, 2016, 3 pages.
Office Action for U.S. Appl. No. 29/520,420, dated Aug. 11, 2016, 18 pages.
Office Action for U.S. Appl. No. 29/530,124, dated Aug. 12, 2016, 17 pages.
Office Action for U.S. Appl. No. 15/272,074, dated Apr. 19, 2017, 54 pages.
Office Action for U.S. Appl. No. 15/272,074, dated Jul. 31, 2017, 34 pages.
Office Action for U.S. Appl. No. 15/272,074, dated Sep. 13, 2017, 5 pages.
Office Action for U.S. Appl. No. 15/272,160, dated Apr. 24, 2017, 39 pages.
Office Action for U.S. Appl. No. 15/272,160, dated Dec. 15, 2017, 34 pages.
Office Action for U.S. Appl. No. 15/272,160, dated Jan. 4, 2017, 31 pages.
Office Action for U.S. Appl. No. 15/272,190, dated Dec. 28, 2017, 22 pages.
Office Action for U.S. Appl. No. 15/272,190, dated Jan. 30, 2017, 32 pages.
Office Action for U.S. Appl. No. 15/272,190, dated Jun. 21, 2017, 7 pages.
Office Action for U.S. Appl. No. 15/272,190, dated May 23, 2017, 36 pages.
Office Action for U.S. Appl. No. 15/288,973, dated Dec. 14, 2016, 21 pages.
Office Action for U.S. Appl. No. 29/520,420, dated Apr. 7, 2017, 3 pages.
Office Action for U.S. Appl. No. 29/520,420, dated Dec. 8, 2017, 5 pages.
Office Action for U.S. Appl. No. 29/520,420, dated Feb. 24, 2017, 14 pages.
Office Action for U.S. Appl. No. 29/520,420, dated Jun. 15, 2017, 12 pages.
Office Action for U.S. Appl. No. 29/530,124, dated Apr. 19, 2017, 6 pages.
Office Action for U.S. Appl. No. 29/530,124, dated Aug. 30, 2017, 3 pages.
Office Action for U.S. Appl. No. 29/530,124, dated Aug. 9, 2017, 11 pages.
Office Action for U.S. Appl. No. 29/530,124, dated Feb. 28, 2017, 16 pages.
Office Action for U.S. Appl. No. 29/530,124, dated Jun. 21, 2017, 14 pages.
Office Action for U.S. Appl. No. 29/530,124, dated Nov. 29, 2017, 31 pages.
Partial Supplementary European Search Report for Application No. 16808466.3, dated Jan. 22, 2019, 14 pages.
Singapore Invitation to Respond to Written Opinion for Application No. 11201610048P, dated Sep. 19, 2017, 16 pages.
Singapore Invitation to Respond to Written Opinion for Application No. 11201701253U, dated Nov. 8, 2017, 12 pages.
Singapore Search Report for Application No. 11201510589T, dated Jan. 31, 2017, 11 pages.
Sleep Medicine Solutions product description, Http://sleepmedicinesolutions.net.au/cpap-spare-parts/26-fisher-paykel-zest-foams.html, downloaded Jul. 28, 2016, 2 pages.
Sleepnet homepage, https://web.archive.org/web/20111021122613/http://www.sleepnetmasks.com/, downloaded Jul. 28, 2016, 4 pages.
Australian Office Action for Application No. 2015305893, dated Jun. 21, 2019, 5 pages.
Chinese Office Action for Application No. 201580044737.6, dated Jun. 20, 2019, 11 pages.
Canadian Office Action for Application No. 2958557, dated Oct. 6, 2021, 6 pages.
Mexican Office Action for Application No. MX/a/2017/000753, dated Sep. 2, 2021, 4 pages including machine translation.
New Zealand Office Action for Application No. 729942, dated Sep. 20, 2021, 3 pages.
Japanese Office Action for Application No. 2020-216060, dated Nov. 30, 2021, 10 pages including translation.
New Zealand Office Action for Application No. 766784, dated Dec. 14, 2021, 3 pages.
Related Publications (1)
Number Date Country
20190232012 A1 Aug 2019 US
Provisional Applications (3)
Number Date Country
62161041 May 2015 US
62078677 Nov 2014 US
62039759 Aug 2014 US
Continuations (2)
Number Date Country
Parent 15272160 Sep 2016 US
Child 16375737 US
Parent 15127758 US
Child 15272160 US